By SterlingMedicalCenter.org Research Team
Affiliate and clinical-review disclosure: SterlingMedicalCenter.org may be compensated through the Official Site link. This multi-specialty review is independent, balanced, and cannot authorize or promise prescription treatment.
Multi-Specialty Safety Overview
- Online program: Remote intake with independent prescribing review
- Price date: July 25, 2026
- Advertised monthly cost: $299 compounded semaglutide; $349 compounded tirzepatide
- Continuity features: Provider follow-up, messages, refill assessment, pharmacy delivery
- Official Site: Confirm the current Sprout Health details
Sprout Health’s online model can make weight-management evaluation easier to reach. A consolidated cash price includes clinical review, follow-up access, medication when prescribed, and shipping. A multi-specialty safety audit asks a second question: will the virtual prescriber see the endocrine, digestive, kidney, eye, surgical, reproductive, and medication issues that may change the decision?
The Endocrine Review
An accurate history should include diabetes care, glucose-lowering medicines, prior reactions, personal or family medullary thyroid carcinoma, and MEN2. The independent licensed provider—not Sprout Health or the applicant—determines whether consultation leads to a prescription and which medication could be appropriate.
Sprout Health markets compounded semaglutide and tirzepatide. Review how online programs differ in our 2026 comparison of GLP-1 telehealth services, but never assume that another program uses an interchangeable preparation.
The Gastrointestinal and Gallbladder Review
Report pancreatitis, gallbladder disease, severe stomach or intestinal disease, persistent vomiting, and previous abdominal symptoms. Ask which symptoms can be watched and which require an urgent examination. A refill should never proceed on the strength of a payment alone when important effects have not been reviewed.
Sprout Health says refill intake begins after the third dose. A clinician reviews it before a next prescription. Portal messages and appointments are available for concerns, which is a positive safety feature when used early.
The Kidney and Hydration Review
Kidney disease and dehydration risk belong in the intake. Vomiting, diarrhea, or sharply reduced intake may alter the plan. Ask the clinician what hydration guidance and monitoring apply to your condition rather than relying on general online advice.
For a broader list of interactions and contraindications, use the Sterling clinical GLP-1 safety guide to prepare the visit. Include every prescription, nonprescription medicine, supplement, allergy, and adverse reaction.
The Eye, Procedure, and Pregnancy Review
Disclose diabetic retinopathy, planned surgery or anesthesia, pregnancy, breastfeeding, and pregnancy plans. These facts may require coordination with an eye clinician, procedural team, or women’s-health professional. Telehealth convenience should not separate one prescription from the rest of the care plan.
The service is not emergency care. Urgent vision changes, severe abdominal pain, breathing difficulty, fainting, or a serious allergic response requires 911 or local emergency evaluation, not a portal message.
The Compounding Review
Compounded medications are not FDA approved and have not been reviewed by FDA for safety, effectiveness, or quality. They are not generic or equivalent versions of FDA-approved brands. Study results from FDA-approved products cannot be transferred to Sprout Health’s compounded formulations.
The platform mentions tablet and injection forms. Those routes should not be assumed to share evidence, absorption, dose, or outcomes. The prescriber must determine the medication, formulation, route, and dose through independent clinical judgment and availability. Ask for the exact concentration and measurement instructions.
The Organization Review
Sprout Health operates the service platform. MD Integrations or another independent clinical network may arrange the medical evaluation. A licensed provider prescribes, if appropriate. A licensed U.S. pharmacy separately compounds and dispenses; Sprout’s terms say the user may identify a different licensed pharmacy.
The current provider, pharmacy, state availability, and applicant eligibility are not established in advance. Keep separate contacts for billing, medical decisions, and preparation or shipping questions.
The Pricing Review
As listed on July 25, 2026, compounded semaglutide is $299 per month and compounded tirzepatide is $349 per month. Sprout Health says each cash price includes provider evaluation, follow-up, clinician messaging, four weeks of medication if prescribed, and shipping. Insurance is not required or billed, and major credit cards are accepted according to the company.
The flat package can aid planning. It cannot guarantee approval, drug supply, route, dose, timing, or results. A $50 first-month code is advertised but may change or expire. Verify checkout. Sprout Health says dose increases do not change the initial subscription rate, apart from one-time discounts. This is its current price-lock claim, not a guarantee.
The Fulfillment and Refund Review
Included shipping follows provider approval and licensed-pharmacy dispensing. Sprout Health markets pharmacy submission within two business days or less and provides delivery windows. Attribute both estimates to the company; provider review, pharmacy work, geography, and the carrier can affect timing.
The subscription is described as month-to-month with no minimum commitment. A full refund may be available before the partner pharmacy processes an order. Processed prescription medication is non-refundable. The buyer must verify the live portal status and current terms before expecting reimbursement.
Multi-Specialty Fit Decision
Potential match: An adult who values online care, accepts compounded-medication limitations, can pay cash, wants follow-up and included shipment, and will disclose information across specialties.
Poor match: Someone wanting an FDA-approved brand, guaranteed prescription, self-selected dose, assured delivery, or emergency support. Complex disease, pregnancy considerations, contraindications, and scheduled procedures require individual coordination and may make the service unsuitable.
Clinical Safeguard Questions
- Which independent prescriber will review all of my specialty care?
- What exact preparation and pharmacy would be involved?
- How should side effects or medication changes be reported before refill?
- What does today’s checkout include after the promotion?
- Has pharmacy processing affected cancellation?
Research Team Conclusion
Sprout Health positively connects online access, independent review, follow-up, refill assessment, pharmacy fulfillment, and shipping. It is safest when each medical specialty concern is visible to the prescriber and when compounding is discussed directly. Read our report on FDA concerns around unapproved GLP-1 products for regulatory context.
Seller-selected testimonials and outcome statements do not demonstrate typical results.
Medical disclaimer: This multi-specialty review provides general education and is not medical care. Independent provider judgment and availability govern all consultation, prescription, formulation, and dosing decisions. Compounded drugs are not FDA approved.